These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 33032294)
1. Formation of IgE-Allergen-CD23 Complex Changes in Children Treated with Subcutaneous Immunotherapy for Japanese Cedar Pollinosis. Asaumi T; Sato S; Yanagida N; Matsuhara H; Kobayashi S; Fukano C; Ohashi-Doi K; Ebisawa M Int Arch Allergy Immunol; 2021; 182(3):190-194. PubMed ID: 33032294 [TBL] [Abstract][Full Text] [Related]
2. Establishment of enzyme-linked immunosorbent facilitated antigen binding as a biomarker assay for Japanese cedar pollen allergy immunotherapy. Fukano C; Ohashi-Doi K; Lund K; Nakao A; Masuyama K; Matsuoka T J Pharmacol Sci; 2019 Jul; 140(3):223-227. PubMed ID: 31353210 [TBL] [Abstract][Full Text] [Related]
3. Pretreatment IgE sensitization patterns determine the molecular profile of the IgG4 response during updosing of subcutaneous immunotherapy with timothy grass pollen extract. Schmid JM; Würtzen PA; Dahl R; Hoffmann HJ J Allergy Clin Immunol; 2016 Feb; 137(2):562-70. PubMed ID: 26141262 [TBL] [Abstract][Full Text] [Related]
9. Allergen-specific subcutaneous immunotherapy for Japanese cedar pollinosis decreases the number of metachromatic cells and eosinophils in nasal swabs during the preseason and in season. Otsuka K; Otsuka H; Matsune S; Okubo K Immun Inflamm Dis; 2020 Sep; 8(3):258-266. PubMed ID: 32239697 [TBL] [Abstract][Full Text] [Related]
10. Allergen-induced basophil CD203c expression as a biomarker for rush immunotherapy in patients with Japanese cedar pollinosis. Nagao M; Hiraguchi Y; Hosoki K; Tokuda R; Usui T; Masuda S; Yamaguchi M; Fujisawa T Int Arch Allergy Immunol; 2008; 146 Suppl 1():47-53. PubMed ID: 18504407 [TBL] [Abstract][Full Text] [Related]
11. Short-term subcutaneous grass pollen immunotherapy under the umbrella of anti-IL-4: A randomized controlled trial. Chaker AM; Shamji MH; Dumitru FA; Calderon MA; Scadding GW; Makatsori M; Jones I; He QA; Subramanian KK; Arm JP; Durham SR; Schmidt-Weber CB J Allergy Clin Immunol; 2016 Feb; 137(2):452-461.e9. PubMed ID: 26531865 [TBL] [Abstract][Full Text] [Related]
12. Immunological and Symptomatic Effects of Oral Intake of Transgenic Rice Containing 7 Linked Major T-Cell Epitopes from Japanese Cedar Pollen Allergens. Endo T; Asaka D; Nakayama T; Saito S; Kodama H; Mitsuyoshi R; Takaishi S; Sugimoto N; Omae S; Takagi H; Wakasa Y; Ozawa K; Takano M; Takaiwa F; Kojima H; Saito S Int Arch Allergy Immunol; 2021; 182(2):109-119. PubMed ID: 32854094 [TBL] [Abstract][Full Text] [Related]
13. Identification of Cha o 3 homolog Cry j 4 from Cryptomeria japonica (Japanese cedar) pollen: Limitation of the present Japanese cedar-specific ASIT. Osada T; Tanaka Y; Yamada A; Sasaki E; Utsugi T Allergol Int; 2018 Oct; 67(4):467-474. PubMed ID: 29525489 [TBL] [Abstract][Full Text] [Related]
14. Association of the MMP9 gene with childhood cedar pollen sensitization and pollinosis. Inoue H; Mashimo Y; Funamizu M; Yonekura S; Horiguchi S; Shimojo N; Kohno Y; Okamoto Y; Hata A; Suzuki Y J Hum Genet; 2012 Mar; 57(3):176-83. PubMed ID: 22237587 [TBL] [Abstract][Full Text] [Related]
15. Safety evaluation of standardized allergen extract of Japanese cedar pollen for sublingual immunotherapy. Mitobe Y; Yokomoto Y; Ohashi-Doi K Regul Toxicol Pharmacol; 2015 Apr; 71(3):529-40. PubMed ID: 25701184 [TBL] [Abstract][Full Text] [Related]
16. [Environmental and immunological survey of sensitization with Japanese cedar (Cryotomeria japonica) pollen in children. Part 2. The clinical significance of Japanese cedar (Cryptomeria japonica) pollen specific IgE antibody and IgG4 antibody]. Takagi M Arerugi; 1992 Nov; 41(11):1540-6. PubMed ID: 1492787 [TBL] [Abstract][Full Text] [Related]
17. [Prophylactic and therapeutic vaccines for Japanese cedar pollinosis]. Ishii Y Nihon Yakurigaku Zasshi; 2010 Jun; 135(6):250-3. PubMed ID: 20543516 [No Abstract] [Full Text] [Related]
18. Sublingual immunotherapy for Japanese cedar pollinosis. Okubo K; Gotoh M Allergol Int; 2009 Jun; 58(2):149-54. PubMed ID: 19390236 [TBL] [Abstract][Full Text] [Related]
19. Recombinant allergen-based monitoring of antibody responses during injection grass pollen immunotherapy and after 5 years of discontinuation. Gadermaier E; Staikuniene J; Scheiblhofer S; Thalhamer J; Kundi M; Westritschnig K; Swoboda I; Flicker S; Valenta R Allergy; 2011 Sep; 66(9):1174-82. PubMed ID: 21480924 [TBL] [Abstract][Full Text] [Related]